Procedure details and outcomes
| Ablation patients (n=16) | |
|---|---|
| Number of septal arteries injected | 2.4±1.4 |
| Amount of ethanol injected, mL | 3.8±2.3 |
| Residual LVOT gradient at rest, mm Hg | 17±16 |
| Peak CK, IU/L | 1180±591 |
| Procedural and in-hospital complications | |
| Pacemaker dependency, n (%) | 0 (0) |
| Cardiac tamponade, n (%) | 0 (0) |
| Sustained ventricular tachycardia, n (%) | 0 (0) |
| Cardiac surgery, n (%) | 0 (0) |
| Resuscitated sudden cardiac arrest, n (%) | 0 (0) |
| Stroke, n (%) | 0 (0) |
| Death, n (%) | 0 (0) |
| Heart failure, n (%) | 0 (0) |
| Clinical events during follow-up period | |
| Pacemaker implantation, n (%) | 0 (0) |
| New ICD, n (%) | 0 (0) |
| Repeat-PTSMA, n (%) | 1 (6) |
| Death, n (%) | 0 (0) |
| Heart failure admission, n (%) | 0 (0) |
Data are expressed as mean±SD or n (%).
CK, creatinine phosphokinase; ICD, implantable cardioverter-defibrillator; LVOT, left ventricular outflow tract; PTSMA, percutaneous transluminal septal myocardial ablation.